ESTHER KOILPILLAI: Open Payments
NPI 1609337252 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 21 payments from 11 companies in 2025. Trend: 2023 $348 · 2024 $726 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $103 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
| HEARTFLOW, INC. | 1 | $19 |
Products named: Wegovy, LifeVest, JARDIANCE, VERQUVO, FARXIGA, Kerendia, LEQVIO, ELIQUIS.
Industry payments across MD — which companies pay providers there.
